课题基金 / 基金详情

项目摘要

项目成果

Michael R. Farzan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY An effective HIV-1 remains an important but elusive goal. One promising approach to such a vaccine uses sequential immunization to guide B-cell receptor (BCR) maturation. To do so, one first amplifies immature unmutated precursors of a particular class of broadly neutralizing antibodies (bNAbs). These precursor BCR are then shepherded to recognize HIV-1 envelope glycoprotein (Env) using increasingly native Env antigens. Sequential immunization strategies for both VRC01- and V3-glycan-classes of bNAbs are being developed. Here we establish the foundations for using the same general strategy to elicit V2-glycan/apex antibodies. Apex bNAbs have properties that both complicate such an approach but ultimately make success more likely. Specifically these bNAbs bind Env largely through their long, acidic and tyrosine-sulfated heavy-chain CDR3 region. Thus there is less need for extensive somatic hypermutaion characteristic of V3-glycan and VRC01-class bNAbs. However, apart from their long sulfated CDR3 regions, apex bNAbs have few distinguishing features. Here we show that we can elicit antibodies in rats with long tyrosine-sulfated CDR3 regions using anti-sulfotyrosine antibodies as antigens. We propose to optimize this approach and use it in concert with oligomeric forms of Env trimers to elicit anti-apex antibodies. These studies will develop a potentially easier approach to generating broad and potent anti-HIV-1 antisera.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
eCD4-mediated control of SIV infection in the brain
  • 批准号:
    10698442
  • 项目类别:
  • 资助金额:
    $91.41万
  • 财政年份:
    2023
  • 负责人:
    Michael R. Farzan
  • 依托单位:
Safe, CRISPR/Cas-free B cell editing for therapeutic applications
  • 批准号:
    10725412
  • 项目类别:
  • 资助金额:
    $22.13万
  • 财政年份:
    2023
  • 负责人:
    Michael R. Farzan
  • 依托单位:
Improving mRNA vaccines with extracellular vesicle-associated immunogens
  • 批准号:
    10573644
  • 项目类别:
  • 资助金额:
    $8.28万
  • 财政年份:
    2022
  • 负责人:
    Michael R. Farzan
  • 依托单位:
Improving mRNA vaccines with extracellular vesicle-associated immunogens
  • 批准号:
    10850617
  • 项目类别:
  • 资助金额:
    $18.96万
  • 财政年份:
    2022
  • 负责人:
    Michael R. Farzan
  • 依托单位:
海外基金